Unit 1136 “Pierre Louis Institute of Epidemiology and Public Health (IPLESP)” firstname.lastname@example.org
+33 (0)1 85 56 02 40
Researchers from Inserm, Sorbonne Université and Université de Bordeaux have published a study based on data from 1,428 children showing that access to a center-based form of childcare between the ages of 0 and 3 years is linked to fewer emotional and peer relationship problems in later life compared with other forms of childcare. These findings were published on October 1, 2018 in Journal of Epidemiology and Community Health.
Researchers from Inserm, Sorbonne Université and Université de Bordeaux (Bordeaux Population Health for Unit 1219) studied in France the impact of the form of childcare used during the three first years of life on the behavioral and emotional development of children. This study is based on 1,428 children from the EDEN cohort (study of the pre- and early postnatal determinants of child health and psychomotor development), based in Nancy and Poitiers which followed up mothers during pregnancy as well as their children up to the age of 8 years.
The mothers reported the main childcare method used for their child at the ages of 4 months, 8 months, 1 year, 2 years and 3 years: informal care (mainly the parents themselves or sometimes the grandparents, neighbors, etc.), home daycare (childminder), or center-based childcare (childcare center, daycare center). Then at 3 years, 5.5 years, and 8 years, they completed the “Strengths and Difficulties Questionnaire” which measures behavioral and emotional symptoms using five scales (emotional symptoms, peer relationship problems, hyperactivity/inattention, conduct problems, and prosocial behavior).
“Access to a center-based form of childcare between the ages of 0 and 3 years represents an opportunity for the children concerned because it is linked to better psychological and emotional development down the line.” explains Inserm researcher, Maria Melchior. These findings taken from data from two cities must now be confirmed on a larger scale.
Inserm researchers at I-Stem – the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases – report encouraging results with metformin, a known diabetes drug, for the symptomatic treatment of Steinert myotonic dystrophy. A phase II trial conducted in 40 patients at ...
A research team from Université Paris Descartes, Inserm and Centre Hospitalier Sainte‐Anne, led by Prof. Marie‐Odile Krebs, has shown that patients suffering from psychotic disorders, and exposed in utero to diethylstilbestrol, presented specific epigenetic changes. These changes correspond to genomic regions notably ...
Ramchandar Gomajee,1 Fabienne El-Khoury,1 Sylvana Côté,2,3, Judith E B van der Waerden1, Laura Pryor,1 Maria Melchior1
1Sorbonne Universités, UPMC Paris 06, INSERM UMRS 1136, Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP), Paris, France
2INSERM U1219, Université de Bordeaux, Bordeaux, France
3Département de Médecine Sociale et Préventive, Université de Montréal, Montreal, Canada
Journal of Epidemiology and Community Health. https://doi.org/10.1136/jech-2017-210393